Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

Share Price is delayed by 15 minutes
Get Live Data
228.00    -1.50 (-0.65%)
Bid:
227.00
Ask:
227.50
Spread: 0.50 (0.22%)
Market Cap: £630.23m
MGAM Live PriceLast checked at - London Stock Exchange

Intraday Morgan Advanced Materials Share Chart

Holding(s) in Company

15 Dec 2015 15:56

RNS Number : 1639J
Morgan Advanced Materials PLC
15 December 2015
 



 TR-1: Notification of Major Interests in Shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Morgan Advanced Materials plc

2. Reason for the notification  (yes/no)

An acquisition or disposal of voting rights

Yes

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

No

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

No

An event changing the breakdown of voting rights

No

Other (please specify): ______________

No

3. Full name of person(s) subject to notification obligation:

 

Black Creek Investment Management Inc.

4. Full name of shareholder(s)  (if different from 3):

Black Creek Absolute Return Fund

Black Creek Global Balanced Corporate Class

Black Creek Global Balanced Fund

Black Creek International Equity Fund

Comcast Corporation Retirement Investment Plan

International Equity Alpha Corporate Class

Select International Equity Managed Corporate Class

Select International Equity Managed Fund

5. Date of transaction  (and date on which the threshold is crossed or reached if different):

11 December 2015

6. Date on which issuer notified:

14 December 2015

7. Threshold(s) that is/are crossed or reached:

Above 5%

8. Notified Details

A: Voting rights attached to shares

Class/type of shares

If possible use ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of voting rights

Number of shares

Number of voting rights

Percentage of voting rights

Indirect

Direct

Indirect

Direct

Indirect

GB0006027295 Common Stock

 14,117,887

 

14,117,887

 

 14,320,390

5.02%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ conversion period

No. of voting rights that may be acquired (if the instrument is exercised/converted)

Percentage of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Exercise Price

Expiration date

Exercise/ conversion period

No. of voting rights instrument refers to

Percentage of voting rights

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

14,320,390

5.02%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will acquire:

12. Date on which proxy holder will acquire voting rights:

13. Additional information:

NONE

14. Contact name:

Stephanie Mackie

Deputy Company Secretary

Morgan Advanced Materials plc

15. Contact telephone number:

01753 837000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEASASFSLSFFF
Date   Source Headline
1st Jun 20264:35 pmRNSDirector/PDMR Shareholding
28th May 202610:10 amRNSHolding(s) in Company
26th May 20265:21 pmRNSDirector/PDMR Shareholding
18th May 20262:53 pmRNSHolding(s) in Company
13th May 20265:26 pmRNSHolding(s) in Company
12th May 20262:09 pmRNSDirector/PDMR Shareholding
7th May 20261:19 pmRNSResult of AGM
7th May 20267:00 amRNSCFO Intention to retire
7th May 20267:00 amRNSAGM Trading Update
29th Apr 20264:23 pmRNSDirector/PDMR Shareholding
9th Apr 20263:51 pmRNSHolding(s) in Company
31st Mar 20261:16 pmRNSDirector/PDMR Shareholding
26th Mar 20265:39 pmRNSDirector/PDMR Shareholding
26th Mar 20269:53 amRNSAnnual Financial Report
24th Mar 20262:44 pmRNSDirector/PDMR Shareholding
9th Mar 20269:34 amRNSDirector/PDMR Shareholding
5th Mar 20269:30 amRNSDirector/PDMR Shareholding
3rd Mar 20267:00 amRNSFull Year Results
23rd Feb 20269:00 amRNSHolding(s) in Company
2nd Feb 20264:12 pmRNSTotal Voting Rights
2nd Feb 20269:30 amRNSHolding(s) in Company
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 202611:57 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSTransaction in Own Shares
24th Dec 20257:00 amRNSTransaction in Own Shares
23rd Dec 20257:00 amRNSTransaction in Own Shares
23rd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 202512:00 pmRNSBlock listing Interim Review
22nd Dec 202512:00 pmRNSBlock listing Interim Review
22nd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
18th Dec 20257:00 amRNSTransaction in Own Shares
17th Dec 20257:00 amRNSTransaction in Own Shares
16th Dec 20257:00 amRNSTransaction in Own Shares
15th Dec 20257:00 amRNSTransaction in Own Shares
12th Dec 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.